<?xml version="1.0" encoding="UTF-8"?>
<p id="para1600">Positivity for anti-HCV in people donating blood to blood banks has been reported to be 0–2%, with clustering around 1% of blood donors.
 <xref rid="bib25" ref-type="bibr">
  <sup>25</sup>
 </xref> Community-based seroprevalence studies have mostly reported similar results,
 <xref rid="bib26" ref-type="bibr">26</xref>, 
 <xref rid="bib27" ref-type="bibr">27</xref> but in some areas such as Punjab state, higher prevalence of 3·2–5·2% has been reported.
 <xref rid="bib28" ref-type="bibr">28</xref>, 
 <xref rid="bib29" ref-type="bibr">29</xref> In a survey of 14 481 people who inject drugs, the weighted anti-HCV prevalence was 37·2% (including 13·2% with HCV-HIV co-infection), varying from 4·9% to 64·9% across 15 Indian cities.
 <xref rid="bib30" ref-type="bibr">
  <sup>30</sup>
 </xref> Indirect evidence suggests that most cases of HCV infection are related either to unsafe injection practices or transfusion of contaminated blood or blood products before the introduction of mandatory testing of donated blood.
 <xref rid="bib25" ref-type="bibr">
  <sup>25</sup>
 </xref>
</p>
